Nav: Home

Researchers find more uses for immune system's 'Swiss army knife'

June 23, 2016

Oxford University research has found that a little-studied and relatively unknown part of the human immune system could be twice as important as previously thought.

Mucosal Associated Invariant T-cells (MAIT cells) were first identified in 1993 but largely ignored until recently. Australian researchers recently found that they had an important role in fighting bacterial infections. Now, the Oxford team, led by Professor Paul Klenerman, say that they also fight viruses. Their results are in the journal Nature Communications.

Researcher Bonnie van Wilgenburg said: 'MAIT cells are unlike any other part of the immune system because they are multipurpose, rather than responding to particular pathogens - the various bacteria, viruses and other microorganism that can cause disease.'

All T-cells recognise and destroy infected human cells to prevent them spreading the infection. Standard T-cells possess specific receptors on their surface, each of which allows them to recognise a different pathogen. Most T-cells have a large range of such receptors to cover all pathogens. One receptor can recognise one particular pathogen infection, while another will be activated by a different pathogen.

MAIT cells have only a few receptors because they do not recognise specific pathogens. Instead they recognise a chemical made by many different pathogens. Researchers in Melbourne identified this chemical: a small molecule called 5-A-RU, which is made by the majority of bacteria. In effect this makes MAIT cell receptors multi-purpose - spotting a whole category of bugs rather than just a set of individual ones.

Now, the team have discovered that MAIT cells are even more multi-purpose than that.

Professor Paul Klenerman explained: 'We found that MAIT cells are readily activated by cytokines, chemical messengers released by the human body in response to infections.'

Cytokines are key parts of the immune system. When released by cells, they trigger certain behaviours in other cells, regulating the body's immune response to match the threat of a pathogen.

Prof Klenerman continued: 'Most human T-cells require their specific receptor to be triggered in order to react, but MAIT cells can bypass this and will be strongly and specifically activated in response to a combination of cytokines.

'In our latest study we discovered that viruses, not just bacteria, can activate the immune system to produce this specific mix of cytokines that activates MAIT cells. By studying people with different viral infections, including flu, dengue and hepatitis C, we found evidence that MAIT cell activation occurs during human viral infection.

'This is the first time that MAIT cells have been observed having a role in the immune response to viruses. This opens up the exciting possibility that MAIT cells could be involved in the defence against viruses or reduce their damaging effects.

'The discovery suggests that MAIT cells are a 'Swiss army knife' for the immune system - useful against all sorts of bacterial and viral infections.'

The discovery may also have implications for vaccine and treatment design. Traditional vaccines stimulate B-cells to produce antibodies that can attack pathogens directly. T-cell vaccines, a focus of current research, are designed to stimulate the production of standard pathogen-specific T cells, which attack infected cells in the body to destroy them and the infection they harbour. But MAIT cells offer another possible treatment route.

However, the Oxford researchers say that we first need to understand more about these unique cells and they will continue to play a key role in that.
-end-


University of Oxford

Related Immune System Articles:

Using the immune system as a defence against cancer
Research published today in the British Journal of Cancer has found that a naturally occurring molecule and a component of the immune system that can successfully target and kill cancer cells, can also encourage immunity against cancer resurgence.
First impressions go a long way in the immune system
An algorithm that predicts the immune response to a pathogen could lead to early diagnosis for such diseases as tuberculosis
Filming how our immune system kill bacteria
To kill bacteria in the blood, our immune system relies on nanomachines that can open deadly holes in their targets.
Putting the break on our immune system's response
Researchers have discovered how a tiny molecule known as miR-132 acts as a 'handbrake' on our immune system -- helping us fight infection.
Decoding the human immune system
For the first time ever, researchers are comprehensively sequencing the human immune system, which is billions of times larger than the human genome.
More Immune System News and Immune System Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...